These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21120624)
1. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9. Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624 [TBL] [Abstract][Full Text] [Related]
2. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro. Parker JL; Ulrich HD Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485 [TBL] [Abstract][Full Text] [Related]
3. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742 [TBL] [Abstract][Full Text] [Related]
4. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783 [TBL] [Abstract][Full Text] [Related]
5. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation. Yan J; Yang XP; Kim YS; Joo JH; Jetten AM Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264 [TBL] [Abstract][Full Text] [Related]
8. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. Schauvliege R; Janssens S; Beyaert R FEBS Lett; 2006 Aug; 580(19):4697-702. PubMed ID: 16884718 [TBL] [Abstract][Full Text] [Related]
9. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659 [TBL] [Abstract][Full Text] [Related]
10. Is Transthyretin a Regulator of Ubc9 SUMOylation? Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389 [TBL] [Abstract][Full Text] [Related]
11. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides. Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016 [TBL] [Abstract][Full Text] [Related]
12. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo. Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673 [TBL] [Abstract][Full Text] [Related]
13. Dynamin interacts with members of the sumoylation machinery. Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615 [TBL] [Abstract][Full Text] [Related]
14. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS). Niedenthal R Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411 [TBL] [Abstract][Full Text] [Related]
15. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion. Kim ET; Kim KK; Matunis MJ; Ahn JH Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459 [TBL] [Abstract][Full Text] [Related]
17. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic. Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification. Nakagawa K; Kuzumaki N Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147 [TBL] [Abstract][Full Text] [Related]
19. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220 [TBL] [Abstract][Full Text] [Related]
20. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation. Zhang J; Goodson ML; Hong Y; Sarge KD J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]